Standard

Optogenetic regulation of endogenous gene transcription in mammals. / Omelina, E. S.; Pindyurin, A. V.

в: Вавиловский журнал генетики и селекции, Том 23, № 2, 01.01.2019, стр. 219-225.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

Omelina, ES & Pindyurin, AV 2019, 'Optogenetic regulation of endogenous gene transcription in mammals', Вавиловский журнал генетики и селекции, Том. 23, № 2, стр. 219-225. https://doi.org/10.18699/VJ19.485

APA

Omelina, E. S., & Pindyurin, A. V. (2019). Optogenetic regulation of endogenous gene transcription in mammals. Вавиловский журнал генетики и селекции, 23(2), 219-225. https://doi.org/10.18699/VJ19.485

Vancouver

Omelina ES, Pindyurin AV. Optogenetic regulation of endogenous gene transcription in mammals. Вавиловский журнал генетики и селекции. 2019 янв. 1;23(2):219-225. doi: 10.18699/VJ19.485

Author

Omelina, E. S. ; Pindyurin, A. V. / Optogenetic regulation of endogenous gene transcription in mammals. в: Вавиловский журнал генетики и селекции. 2019 ; Том 23, № 2. стр. 219-225.

BibTeX

@article{50e5a4c292ac4a89b04e904f92c75a81,
title = "Optogenetic regulation of endogenous gene transcription in mammals",
abstract = "Despite the rapid development of approaches aimed to precisely control transcription of exogenous genes in time and space, design of systems providing similar tight regulation of endogenous gene expression is much more challenging. However, finding ways to control the activity of endogenous genes is absolutely necessary for further progress in safe and effective gene therapies and regenerative medicine. In addition, such systems are of particular interest for genetics, molecular and cell biology. An ideal system should ensure tunable and reversible spatio-temporal control over transcriptional activity of a gene of interest. Although there are drug-inducible systems for transcriptional regulation of endogenous genes, optogenetic approaches seem to be the most promising for the gene therapy applications, as they are noninvasive and do not exhibit toxicity in comparison with drug-inducible systems. Moreover, they are not dependent on chemical inducer diffusion rate or pharmacokinetics and exhibit fast activation-deactivation switching. Among optogenetic tools, long-wavelength light-controlled systems are more preferable for use in mammalian tissues in comparison with tools utilizing shorter wavelengths, since far-red/near-infrared light has the maximum penetration depth due to lower light scattering caused by lipids and reduced tissue autofluorescence at wavelengths above 700 nm. Here, we review such light-inducible systems, which are based on synthetic factors that can be targeted to any desired DNA sequence and provide activation or repression of a gene of interest. The factors include zinc finger proteins, transcription activator-like effectors (TALEs), and the CRISPR/Cas9 technology. We also discuss the advantages and disadvantages of these DNA targeting tools in the context of the light-inducible gene regulation systems.",
keywords = "CRISPR/Cas9, Optogenetics, TALE, Transcription regulation, Zinc finger, transcription regulation, CRISPR, ZINC FINGERS, ACTIVATION, RNA, CRYSTAL-STRUCTURE, DNA RECOGNITION, optogenetics, INDUCTION, zinc finger, SPATIOTEMPORAL CONTROL, PROTEIN INTERACTIONS, EXPRESSION",
author = "Omelina, {E. S.} and Pindyurin, {A. V.}",
note = "Publisher Copyright: {\textcopyright} Omelina E.S., Pindyurin A.V., 2019",
year = "2019",
month = jan,
day = "1",
doi = "10.18699/VJ19.485",
language = "English",
volume = "23",
pages = "219--225",
journal = "Вавиловский журнал генетики и селекции",
issn = "2500-0462",
publisher = "Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences",
number = "2",

}

RIS

TY - JOUR

T1 - Optogenetic regulation of endogenous gene transcription in mammals

AU - Omelina, E. S.

AU - Pindyurin, A. V.

N1 - Publisher Copyright: © Omelina E.S., Pindyurin A.V., 2019

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Despite the rapid development of approaches aimed to precisely control transcription of exogenous genes in time and space, design of systems providing similar tight regulation of endogenous gene expression is much more challenging. However, finding ways to control the activity of endogenous genes is absolutely necessary for further progress in safe and effective gene therapies and regenerative medicine. In addition, such systems are of particular interest for genetics, molecular and cell biology. An ideal system should ensure tunable and reversible spatio-temporal control over transcriptional activity of a gene of interest. Although there are drug-inducible systems for transcriptional regulation of endogenous genes, optogenetic approaches seem to be the most promising for the gene therapy applications, as they are noninvasive and do not exhibit toxicity in comparison with drug-inducible systems. Moreover, they are not dependent on chemical inducer diffusion rate or pharmacokinetics and exhibit fast activation-deactivation switching. Among optogenetic tools, long-wavelength light-controlled systems are more preferable for use in mammalian tissues in comparison with tools utilizing shorter wavelengths, since far-red/near-infrared light has the maximum penetration depth due to lower light scattering caused by lipids and reduced tissue autofluorescence at wavelengths above 700 nm. Here, we review such light-inducible systems, which are based on synthetic factors that can be targeted to any desired DNA sequence and provide activation or repression of a gene of interest. The factors include zinc finger proteins, transcription activator-like effectors (TALEs), and the CRISPR/Cas9 technology. We also discuss the advantages and disadvantages of these DNA targeting tools in the context of the light-inducible gene regulation systems.

AB - Despite the rapid development of approaches aimed to precisely control transcription of exogenous genes in time and space, design of systems providing similar tight regulation of endogenous gene expression is much more challenging. However, finding ways to control the activity of endogenous genes is absolutely necessary for further progress in safe and effective gene therapies and regenerative medicine. In addition, such systems are of particular interest for genetics, molecular and cell biology. An ideal system should ensure tunable and reversible spatio-temporal control over transcriptional activity of a gene of interest. Although there are drug-inducible systems for transcriptional regulation of endogenous genes, optogenetic approaches seem to be the most promising for the gene therapy applications, as they are noninvasive and do not exhibit toxicity in comparison with drug-inducible systems. Moreover, they are not dependent on chemical inducer diffusion rate or pharmacokinetics and exhibit fast activation-deactivation switching. Among optogenetic tools, long-wavelength light-controlled systems are more preferable for use in mammalian tissues in comparison with tools utilizing shorter wavelengths, since far-red/near-infrared light has the maximum penetration depth due to lower light scattering caused by lipids and reduced tissue autofluorescence at wavelengths above 700 nm. Here, we review such light-inducible systems, which are based on synthetic factors that can be targeted to any desired DNA sequence and provide activation or repression of a gene of interest. The factors include zinc finger proteins, transcription activator-like effectors (TALEs), and the CRISPR/Cas9 technology. We also discuss the advantages and disadvantages of these DNA targeting tools in the context of the light-inducible gene regulation systems.

KW - CRISPR/Cas9

KW - Optogenetics

KW - TALE

KW - Transcription regulation

KW - Zinc finger

KW - transcription regulation

KW - CRISPR

KW - ZINC FINGERS

KW - ACTIVATION

KW - RNA

KW - CRYSTAL-STRUCTURE

KW - DNA RECOGNITION

KW - optogenetics

KW - INDUCTION

KW - zinc finger

KW - SPATIOTEMPORAL CONTROL

KW - PROTEIN INTERACTIONS

KW - EXPRESSION

UR - http://www.scopus.com/inward/record.url?scp=85065015588&partnerID=8YFLogxK

U2 - 10.18699/VJ19.485

DO - 10.18699/VJ19.485

M3 - Article

AN - SCOPUS:85065015588

VL - 23

SP - 219

EP - 225

JO - Вавиловский журнал генетики и селекции

JF - Вавиловский журнал генетики и селекции

SN - 2500-0462

IS - 2

ER -

ID: 20181821